Achilles Therapeutics plc

Achilles Therapeutics plcverified

ACHL

Price:

$0.9812

Market Cap:

$40.33M

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therap...[Read more]

Industry

Biotechnology

IPO Date

2021-03-31

Stock Exchange

NASDAQ

Ticker

ACHL

The Current Ratio as of December 2024 (TTM) for Achilles Therapeutics plc (ACHL) is 6.04

According to Achilles Therapeutics plc’s latest financial reports and current stock price. The company's current Current Ratio is 6.04. This represents a change of -25.57% compared to the average of 8.12 of the last 4 quarters.

Achilles Therapeutics plc (ACHL) Historical Current Ratio (quarterly & annually)

How has ACHL Current Ratio performed in the past?

The mean historical Current Ratio of Achilles Therapeutics plc over the last ten years is 13.80. The current 6.04 Current Ratio has changed 4.28% with respect to the historical average. Over the past ten years (40 quarters), ACHL's Current Ratio was at its highest in in the June 2019 quarter at 26.72. The Current Ratio was at its lowest in in the September 2024 quarter at 6.04.

Quarterly (TTM)
Annual

Average

13.80

Median

11.11

Minimum

8.57

Maximum

26.72

Achilles Therapeutics plc (ACHL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Achilles Therapeutics plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 156.90%

Maximum Annual Current Ratio = 26.72

Minimum Annual Increase = -57.72%

Minimum Annual Current Ratio = 8.57

Quarterly (TTM)
Annual
YearCurrent RatioChange
20238.57-21.57%
202210.93-26.68%
202114.9031.89%
202011.30-57.72%
201926.72156.90%

Achilles Therapeutics plc (ACHL) Average Current Ratio

How has ACHL Current Ratio performed in the past?

The current Current Ratio of Achilles Therapeutics plc (ACHL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

11.46

5-year avg

14.48

10-year avg

13.80

Achilles Therapeutics plc (ACHL) Current Ratio vs. Peers

How is ACHL’s Current Ratio compared to its peers?

Achilles Therapeutics plc’s Current Ratio is greater than Assembly Biosciences, Inc. (2.36), greater than Spero Therapeutics, Inc. (2.68), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), less than Nuvation Bio Inc. (9.57), greater than CytomX Therapeutics, Inc. (1.04), less than NextCure, Inc. (9.07),

Build a custom stock screener for Achilles Therapeutics plc (ACHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achilles Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achilles Therapeutics plc (ACHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achilles Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Achilles Therapeutics plc's Current Ratio?

How is the Current Ratio calculated for Achilles Therapeutics plc (ACHL)?

What is the highest Current Ratio for Achilles Therapeutics plc (ACHL)?

What is the 3-year average Current Ratio for Achilles Therapeutics plc (ACHL)?

What is the 5-year average Current Ratio for Achilles Therapeutics plc (ACHL)?

How does the current Current Ratio for Achilles Therapeutics plc (ACHL) compare to its historical average?